Health Canada Accepts New Drug Submission for Trofinetide Acadia Pharmaceuticals is pleased to share that Health Canada has accepted their New Drug Submission (NDS) of trofinetide for the treatment of Rett Syndrome. Moreover, the treatment has been granted Priority Review to… Read More
News
Tag: Trofinetide
Health Canada Accepts a New Drug Submission
Last Updated: 04/24/2024 by Steve Leave a Comment
Health Canada Accepts New Drug Submission for Trofinetide Acadia Pharmaceuticals is pleased to share that Health Canada has accepted their New Drug Submission (NDS) of trofinetide for the treatment of Rett Syndrome. Moreover, the treatment has been granted Priority Review to… Read More
Category: Latest Research, News, Press Releases, Top Slider Tags: 2024, Acadia, Health Canada, Trofinetide